These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10357412

  • 21. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Collarino A, de Koster EJ, Valdés Olmos RA, de Geus-Oei LF, Pereira Arias-Bouda LM.
    Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
    [Abstract] [Full Text] [Related]

  • 22. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S, Primi F, Capoccetti F, Scopinaro F, Modesti M, Schillaci O.
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [Abstract] [Full Text] [Related]

  • 23. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R, Linke R, Untch M, Richter A, Fieber S, Brinkbäumer K, Tatsch K, Hahn K.
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [Abstract] [Full Text] [Related]

  • 24. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).
    Danishad KK, Sharma U, Sah RG, Seenu V, Parshad R, Jagannathan NR.
    NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134
    [Abstract] [Full Text] [Related]

  • 25. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
    Wright FC, Zubovits J, Gardner S, Fitzgerald B, Clemons M, Quan ML, Causer P.
    J Surg Oncol; 2010 Jun 01; 101(7):604-10. PubMed ID: 20461768
    [Abstract] [Full Text] [Related]

  • 26. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
    Listewnik MH, Birkenfeld B, Foszczyńska-Kłoda M, Listewnik MJ, Piwowarska-Bilska H, Zorga P.
    Ann Acad Med Stetin; 2011 Jun 01; 57(1):73-8. PubMed ID: 22593995
    [Abstract] [Full Text] [Related]

  • 27. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU, Nasir Z, Raza T, Hashmi H, Hashmi A, Fatima N.
    J Coll Physicians Surg Pak; 2009 Mar 01; 19(3):173-8. PubMed ID: 19268018
    [Abstract] [Full Text] [Related]

  • 28. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
    Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C.
    J Nucl Med; 1997 Oct 01; 38(10):1546-51. PubMed ID: 9379190
    [Abstract] [Full Text] [Related]

  • 29. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
    Marshall C, Eremin J, El-Sheemy M, Eremin O, Griffiths PA.
    Nucl Med Commun; 2005 Jan 01; 26(1):9-15. PubMed ID: 15604942
    [Abstract] [Full Text] [Related]

  • 30. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R, Kessler M, Untch M, Sommer H, Linke R, Brinkbäumer K, Hahn K.
    Onkologie; 2003 Feb 01; 26(1):27-31. PubMed ID: 12624514
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R, Pasqualoni R, Bergomi S, Petrilli G, Vici P, Belli F, Botti C, Mottolese M, Maini CL.
    J Nucl Med; 2002 Jun 01; 43(6):745-51. PubMed ID: 12050317
    [Abstract] [Full Text] [Related]

  • 32. Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy.
    Novikov SN, Kanaev SV, Petr KV, Tatyana SY, Elena TA, Ludmila JA, Nikolay ID, Zhanna BV, Pavel KI.
    Nucl Med Commun; 2015 Aug 01; 36(8):795-801. PubMed ID: 26011586
    [Abstract] [Full Text] [Related]

  • 33. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
    Schott AF, Roubidoux MA, Helvie MA, Hayes DF, Kleer CG, Newman LA, Pierce LJ, Griffith KA, Murray S, Hunt KA, Paramagul C, Baker LH.
    Breast Cancer Res Treat; 2005 Aug 01; 92(3):231-8. PubMed ID: 16155794
    [Abstract] [Full Text] [Related]

  • 34. Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting.
    Evangelista L, Cervino AR, Sanco R, Bignotto M, Saibene T, Michieletto S, Ghiotto C, Bozza F, Paiusco M, Saladini G.
    Breast Cancer Res Treat; 2014 Jul 01; 146(2):331-40. PubMed ID: 24939059
    [Abstract] [Full Text] [Related]

  • 35. Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.
    Soliman H, Gunasekara A, Rycroft M, Zubovits J, Dent R, Spayne J, Yaffe MJ, Czarnota GJ.
    Clin Cancer Res; 2010 May 01; 16(9):2605-14. PubMed ID: 20406836
    [Abstract] [Full Text] [Related]

  • 36. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Guo C, Zhang C, Liu J, Tong L, Huang G.
    Nucl Med Commun; 2016 Jul 01; 37(7):675-88. PubMed ID: 26974314
    [Abstract] [Full Text] [Related]

  • 37. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M.
    J Clin Oncol; 1998 May 01; 16(5):1677-83. PubMed ID: 9586878
    [Abstract] [Full Text] [Related]

  • 38. [The role of scintimammography with 99mTs-technetril to predict the pathologic status of regional lymph nodes in patients with locally advanced breast cancer after neoadjuvant chemotherapy].
    Bryantseva ZhV, Kanaev SV, Semiglazov VF, Novikov SN, Krivorotko PV, Klimenko VV, Trufanova ES, Kotova ZS, Chernaya AV, Turkevich EA, Semiglazova TY.
    Vopr Onkol; 2015 May 01; 61(2):185-8. PubMed ID: 26087595
    [Abstract] [Full Text] [Related]

  • 39. Functional breast imaging with Tc 99m Mibi for detection of primary breast lesion and axillary lymph node metastases.
    Usmani S, Khan HA, Javed A, Al Mohannadi S, Al Huda FA, Al Shammary I.
    Gulf J Oncolog; 2008 Jul 01; (4):52-7. PubMed ID: 20084776
    [Abstract] [Full Text] [Related]

  • 40. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
    Chen J, Wu H, Zhou J, Hu J.
    Chin Med J (Engl); 2003 Apr 01; 116(4):620-4. PubMed ID: 12875735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.